title: Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.
authors: Jon
authors: J
authors: Cohen
mesh_terms: D000998:Antiviral Agents / Q000191:economics* / Q000494:pharmacology / Q000627:therapeutic use; D003254:Consumer Advocacy; D017281:Cost of Illness; D017277:Drug Approval; D016568:Drugs, Generic / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D016174:Hepacivirus / Q000187:drug effects / Q000235:genetics; D006526:Hepatitis C / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology; D006801:Humans; D015995:Prevalence; D000069474:Sofosbuvir; D014481:United States; D014486:United States Food and Drug Administration; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D016568:Drugs, Generic; D014542:Uridine Monophosphate; D000069474:Sofosbuvir